Pharmaceutical News

RSS

QUT molecular microbiologist developing new therapies to beat bacterial superbugs

QUT molecular microbiologist Makrina Totsika is at the forefront of research to develop new therapies to beat multi-drug resistant bacteria.

22 Aug 2016

New study examines effectiveness of pictogram labels on medication-related road traffic crash risk

A new study questions the effectiveness of using pictogram message on the labels of anxiety and sleep medications that interfere with driving - an approach this is currently implemented across France.

22 Aug 2016

NYIT researcher aims to study link between wound healing problems and methamphetamine use

A chance observation in a Southern California fast food restaurant led Luis Martinez, Ph.D., to wonder about the connections behind wound healing problems and methamphetamine use.

19 Aug 2016

Genekam develops first therapeutic molecule candidate for Zika viruses

GenekamBiotechnology AG, which developed the first test for Zika virus detection in January 2016, has developed as one of first company in the world the therapeutic molecule candidate for Zika viruses, which is likely to be the first potential candidate for Zika-virus therapy.

19 Aug 2016

Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit

Nivolumab has been approved since April 2016 as a checkpoint inhibitor for the treatment of adults with locally advanced or metastatic nonsquamous non-small-cell lung cancer (NSCLC) who have already undergone chemotherapy.

19 Aug 2016

Added benefit of combination drug for HIV-infected patients not proven

The drug combination emtricitabine/tenofovir alafenamide is approved in combination with other antiviral agents for the treatment of adults and adolescents infected with human immunodeficiency virus type 1 (HIV-1).

19 Aug 2016

Added benefit of lung cancer drug not proven, says IQWiG

Afatinib (trade name: Giotrif) has been approved since April 2016 for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) of squamous histology who have already received chemotherapy.

19 Aug 2016

Added benefit not proven for orphan drug in treatment of adults with stomach cancer

Ramucirumab (trade name: Cyramza) is a monoclonal antibody, which blocks a receptor, reducing the growth of blood vessels and so reducing blood supply to the tumours.

19 Aug 2016

Added benefit still not proven for epilepsy drug

Brivaracetam (trade name: Briviact) has been approved since January 2016 as add-on therapy for adults and adolescents from 16 years of age with epileptic seizures.

19 Aug 2016

Many parents support HPV vaccine school-entry requirements with opt-out provisions

Requiring students to get vaccinated against the human papillomavirus, or HPV, to enter school could prevent many cancers linked to the virus, but University of North Carolina at Chapel Hill researchers found that many parents only support such requirements with opt-out provisions that could make the laws less effective.

19 Aug 2016

Men experience greater pain relief than women after smoking marijuana, study finds

Researchers from Columbia University Medical Center found that men had greater pain relief than women after smoking marijuana.

19 Aug 2016

TSRI scientists find evidence supporting new therapeutic strategy against cocaine addiction

An international team led by scientists at The Scripps Research Institute has found strong evidence supporting a new strategy against drug addiction.

18 Aug 2016

Popular pain and fever reliever does not worsen asthma in children, study shows

WIn a study of children with mild, persistent asthma, scientists found that acetaminophen was tolerated without the worsening of asthma, when compared with ibuprofen use.

18 Aug 2016

Diabetes medication offers protection against arterial stiffness in overweight female mice

Obesity and Type 2 diabetes are associated with vascular stiffening and the development of cardiovascular disease.

18 Aug 2016

Research findings open avenues for creating new classes of anticancer drugs

A new study at Los Alamos National Laboratory and in collaboration with Stanford Synchrotron Radiation Lightsource greatly improves scientists' understanding of the element actinium. The insights could support innovation in creating new classes of anticancer drugs.

18 Aug 2016

New book from Cold Spring Harbor examines major antibiotics and mechanisms of resistance

One of the greatest medical accomplishments of the past century was the introduction of antibiotics into the clinic.

18 Aug 2016

Low adherence to antipsychotic medication linked to long-term homelessness

SFU health sciences researcher Stefanie Rezansoff has published a new study on the treatment of serious mental illnesses among people who are homeless. This is the first study to investigate adherence to antipsychotic medication in this population.

18 Aug 2016

T-sol can be safe and effective treatment for men with hypogonadism

For men with hypogonadism, a condition in which the body does not produce enough testosterone, low sex drive and fatigue are common symptoms.

17 Aug 2016

Steroid treatment linked to increased risk of retinopathy in very low birth weight infants

Because of the beneficial effect of corticosteroids on lung function, especially in infants who are ventilator dependent, corticosteroids are, at times, administered to very low birth weight neonates to treat established or evolving lung disease. However, it has long been suspected that steroids may have negative neurodevelopmental effects on very premature infants.

16 Aug 2016

New guidance provides effective practices for prehospital use of TXA in injured patients

Tranexamic acid (TXA) is currently being administered to injured patients by many prehospital air and ground systems, despite a lack of evidence supporting or refuting its efficacy in preventing hemorrhage.

16 Aug 2016

Pharmaceutical News

QUT molecular microbiologist developing new therapies to beat bacterial superbugs

New study examines effectiveness of pictogram labels on medication-related road traffic crash risk

NYIT researcher aims to study link between wound healing problems and methamphetamine use

Genekam develops first therapeutic molecule candidate for Zika viruses

Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit

Added benefit of combination drug for HIV-infected patients not proven

Added benefit of lung cancer drug not proven, says IQWiG

Added benefit not proven for orphan drug in treatment of adults with stomach cancer

Added benefit still not proven for epilepsy drug

Many parents support HPV vaccine school-entry requirements with opt-out provisions

Men experience greater pain relief than women after smoking marijuana, study finds

TSRI scientists find evidence supporting new therapeutic strategy against cocaine addiction

Popular pain and fever reliever does not worsen asthma in children, study shows

Diabetes medication offers protection against arterial stiffness in overweight female mice

Research findings open avenues for creating new classes of anticancer drugs

New book from Cold Spring Harbor examines major antibiotics and mechanisms of resistance

Low adherence to antipsychotic medication linked to long-term homelessness

T-sol can be safe and effective treatment for men with hypogonadism

Steroid treatment linked to increased risk of retinopathy in very low birth weight infants

New guidance provides effective practices for prehospital use of TXA in injured patients

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News